Join to View Full Profile
110 Francis StSte GbBoston, MA 02215
Phone+1 617-632-7706
Dr. Trevejo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 2004 - 2008
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
Weill Cornell MedicineClass of 2002
Certifications & Licensure
MA State Medical License 2004 - 2026
Clinical Trials
- A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 85 citationsImplications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.Nikolai Eroshenko, Taylor Gill, Marianna K Keaveney, George M. Church, Jose M Trevejo
Nature Biotechnology. 2020-07-01 - 61 citationsSafety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-control...Ellie Hershberger, Susan Sloan, Kristin Narayan, Catherine A. Hay, Patrick F. Smith
Ebiomedicine. 2019-02-01 - 42 citationsPimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: a Phase IIa, randomized, double-blind, placebo-controlled study.Jose M Trevejo, Mohammed Asmal, Johan Vingerhoets, Ramon Polo, Sarah Robertson
Antiviral Therapy. 2017-05-01
Press Mentions
Rocket Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent ProgressMay 10th, 2021- Sorrento Enters into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting with Neutralizing Antibodies to Treat COVID-19 and Cancer TherapeuticsAugust 20th, 2020
Visterra Announces Publication of Clinical Data on VIS410 in the Journal EBioMedicineFebruary 26th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
